La terapia enzimatica sostitutiva nella malattia di Fabry
Anderson-Fabry disease (FD) is a X-linked lysosomal storage disorder, which involves glycosphingolipids metabolism. Specific treatment for FD has been available in the last two decades, after the development and commercialization of recombinant human alfa-galactosidase A. Since then enzyme replacem...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Italian |
| Published: |
AboutScience Srl
2019-09-01
|
| Series: | Giornale di Clinica Nefrologia e Dialisi |
| Online Access: | https://journals.aboutscience.eu/index.php/gcnd/article/view/528 |